These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [The methods of administration and dosage are more important than the medicines in angiography]. Jacquet M Angeiologie; 1968; 20(1):19-27. PubMed ID: 5682232 [No Abstract] [Full Text] [Related]
46. [Critique on the use of the intra-arterial route for drug administration in arterial diseases of the lower extremities]. TRENCH NF; GUERRA JC Rev Paul Med; 1957 Feb; 50(2):95-102. PubMed ID: 13442157 [No Abstract] [Full Text] [Related]
47. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders]. Weber G; Vogel A Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908 [No Abstract] [Full Text] [Related]
48. [Evaluation of the use of vascular agents in massive acute hemorrhage]. Uvarov BS; Gel'd VG Eksp Khir Anesteziol; 1973; 18(3):56-8. PubMed ID: 4149335 [No Abstract] [Full Text] [Related]
49. The use and abuse of vasodilator drugs. Rose SS Vasc Dis; 1967 Apr; 4(2):67-82. PubMed ID: 6027150 [No Abstract] [Full Text] [Related]
50. [Rheographic studies of the peripheral vasodilating action of Halidor]. Kusztos D Orv Hetil; 1968 May; 109(21):Suppl:29-31. PubMed ID: 5720719 [No Abstract] [Full Text] [Related]
51. A clinical and laboratory comparison of the effects of commonly used vasodilator drugs on arterial diseases. STALLWORTH JM; LEE WH; BELISLE C; NUNN DB Am Surg; 1958 Oct; 24(10):700-8. PubMed ID: 13583455 [No Abstract] [Full Text] [Related]
52. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases]. Chiti E Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388 [No Abstract] [Full Text] [Related]
53. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders]. Hamming JJ; van der Drift JH Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995 [No Abstract] [Full Text] [Related]
54. [Experiences with a new therapeutic agent for stenocardia]. HANKE H Dtsch Med J; 1958 Aug; 9(8):432-3. PubMed ID: 13573972 [No Abstract] [Full Text] [Related]
55. [First observations on the therapeutic action of a new synthetic coronary vasokilator; 7-alpha-(acetoxyethane)-oxyflavone]. TARTARA A; CORBETTA F Folia Cardiol; 1956 Oct; 15(5):539-49. PubMed ID: 13405097 [No Abstract] [Full Text] [Related]
56. [Vasodilator agents]. Bollinger A Schweiz Med Wochenschr; 1967 Sep; 97(37):1225-7. PubMed ID: 4874428 [No Abstract] [Full Text] [Related]
57. [Various new ideas in the medical treatment of angiopathy]. Pratesi F; Tesi M; Brunetti S; Spinelli P; Corsi C; Caramelli L; Dabizzi RP Angeiologie; 1968; 20(1):37-62. PubMed ID: 5693137 [No Abstract] [Full Text] [Related]
58. [Neurogenic control of venous hypertension in cardiac insufficiency]. BUZZI A; SANDOZ JR Prensa Med Argent; 1958 Mar; 45(10):1032-6. PubMed ID: 13591223 [No Abstract] [Full Text] [Related]
59. [Diagnosis and therapy of peripheral disorders of the blood circulation with special consideration of the effect of beta pyridyl carbinol]. Broghammer H Med Welt; 1967 Apr; 17():1091-100. PubMed ID: 5586962 [No Abstract] [Full Text] [Related]
60. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? Cleland JG Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]